Paroxysmal Nocturnal Hemoglobinuria PNH Active Not Recruiting Phase 2 Trials for Tesidolumab (DB11926)

IndicationStatusPhase
DBCOND0088728 (Paroxysmal Nocturnal Hemoglobinuria PNH)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02534909Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal HemoglobinuriaTreatment